Literature DB >> 15962500

Systemic adverse effects of topical ocular treatments.

Marc Labetoulle1, Eric Frau, Claire Le Jeunne.   

Abstract

Some eyedrops, gels or ointments may cause adverse effects as serious as those observed with systemic therapies. Because of their relatively poor penetration into eye tissue, ophthalmic drugs usually contain high concentrations of their active ingredient. Asking patients about these drugs to prevent interactions is useful when prescribing a new systemic treatment. Conversely, it is advisable to ask about ophthalmic drugs during the etiological investigation of possible iatrogenic effects.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15962500     DOI： 10.1016/s0755-4982(05)83987-9

Source DB:  PubMed          Journal:  Presse Med        ISSN： 0755-4982            Impact factor:   1.228


  7 in total

Review 1.  Drug-induced urinary retention: incidence, management and prevention.

Authors:  Katia M C Verhamme; Miriam C J M Sturkenboom; Bruno H Ch Stricker; Ruud Bosch
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

2.  Characterizing Current Attitudes and Practices for Human Subject Safety in Studies Involving Pupil Dilation.

Authors:  Jacob Szpernal; Joseph Carroll; Ryan Spellecy; Jane A Bachman Groth
Journal:  J Empir Res Hum Res Ethics       Date:  2020-11-02       Impact factor: 1.742

3.  Synthesis and Characterization of Poly(2-hydroxyethylmethacrylate) Contact Lenses Containing Chitosan Nanoparticles as an Ocular Delivery System for Dexamethasone Sodium Phosphate.

Authors:  Gautam Behl; Javed Iqbal; Niall J O'Reilly; Peter McLoughlin; Laurence Fitzhenry
Journal:  Pharm Res       Date:  2016-03-10       Impact factor: 4.200

4.  Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction.

Authors:  Henny J M Beckers; Jan S A G Schouten; Carroll A B Webers; Rikkert van der Valk; Fred Hendrikse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-25       Impact factor: 3.117

Review 5.  Ocular medicines in children: the regulatory situation related to clinical research.

Authors:  Filomena Fortinguerra; Antonio Clavenna; Maurizio Bonati
Journal:  BMC Pediatr       Date:  2012-01-20       Impact factor: 2.125

6.  When color helps.

Authors:  Ana Luiza Fontes de Azevedo Costa; Thiago Gonçalves Dos Santos Martins; Ricardo Vieira Martins; Paulo Schor
Journal:  Einstein (Sao Paulo)       Date:  2018-12-17

7.  A Drug Safety Surveillance Study of a Ciprofloxacin/Dexamethasone Ophthalmic Fixed Combination in Peruvian Population.

Authors:  Homero Contreras-Salinas; Leopoldo Martín Baiza-Durán; Mariana Barajas-Hernández; Alan Omar Vázquez-Álvarez; Lourdes Yolotzin Rodríguez-Herrera
Journal:  Pharmacy (Basel)       Date:  2021-01-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.